A. S. Suyundukova
A. S. Suyundukova has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- B. M. Blokhin
Pirogov Russian National Research Medical University
4 shared publications - G. I. Gordienko
ФГАОУ ВО РНИМУ имени Н.И. Пирогова Минздрава России (Пироговский Университет)
3 shared publications - A.D. Prokhorova2 shared publications
- I.P. Lobushkova2 shared publications
- V. Yu. Steshin
Pirogov Russian National Research Medical University
2 shared publications - A. V. Korolev
Pirogov Russian National Research Medical University
1 shared publication
Latest Publications
- 31 March 2025
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 29 (1(29))
Стратегия диагностики латентной туберкулезной инфекции у детей с атопическими заболеваниями
Рассматривается современная стратегия диагностики туберкулезной инфекции (ТБИ) у детей, страдающих атопическими заболеваниями, такими как бронхиальная астма, аллергический ринит и атопический дерматит. Учитывая сложности в интерпретации результатов иммунодиагностики туберкулезной инфекции у детей с атопией, данное исследование подчеркивает важность раннего выявления и мониторинга латентной туберкулезной инфекции у этой категории пациентов. В статье представлен анализ применения современных внутрикожных проб, а также обсуждение особенностей интерпретации результатов иммунодиагностики у детей с атопическими заболеваниями. Отмечено, что применение пробы с аллергеном туберкулезным рекомбинантным (АТР) — Диаскинтест® (АО Генериум, Россия) позволяет провести дифференциальную диагностику туберкулезного инфицирования и поствакцинальной аллергии у детей в рамках амбулаторно-поликлинического звена, не используя дополнительные методы исследования, не прибегая к посещению противотуберкулезных учреждений, что снижает уровень тревожности и улучшает качество жизни пациентов и их родителей/законных представителей.
- 31 March 2025
- Published by OOO "Opponent" in Медицинский оппонент
- Vol. 29 (1(29))
Стратегия диагностики латентной туберкулезной инфекции у детей с атопическими заболеваниями
Рассматривается современная стратегия диагностики туберкулезной инфекции (ТБИ) у детей, страдающих атопическими заболеваниями, такими как бронхиальная астма, аллергический ринит и атопический дерматит. Учитывая сложности в интерпретации результатов иммунодиагностики туберкулезной инфекции у детей с атопией, данное исследование подчеркивает важность раннего выявления и мониторинга латентной туберкулезной инфекции у этой категории пациентов. В статье представлен анализ применения современных внутрикожных проб, а также обсуждение особенностей интерпретации результатов иммунодиагностики у детей с атопическими заболеваниями. Отмечено, что применение пробы с аллергеном туберкулезным рекомбинантным (АТР) — Диаскинтест® (АО Генериум, Россия) позволяет провести дифференциальную диагностику туберкулезного инфицирования и поствакцинальной аллергии у детей в рамках амбулаторно-поликлинического звена, не используя дополнительные методы исследования, не прибегая к посещению противотуберкулезных учреждений, что снижает уровень тревожности и улучшает качество жизни пациентов и их родителей/законных представителей.
- Open Access
- 20 March 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (1) , 26-32
Pharmacoepidemiological study of treatment of frequently ill children: analysis of preferences of primary care pediatricians in choosing therapy
Objective: A survey of 464 primary care pediatricians was conducted to determine the choice of therapy for a group of frequently ill children depending on their length of service: from 3 to 10 years or more.Results: Recurrent acute respiratory infections are a complex problem for treating physicians. There is no consensus on the tactics of managing a group of frequently ill children among practicing pediatricians with different lengths of service. Preventive strategies come to the forefront to minimize the frequency of acute respiratory infections.
- 20 March 2025
- Published by Journal of Childrens Infections in CHILDREN INFECTIONS
- Vol. 24 (1) , 26-32
Open AccessPharmacoepidemiological study of treatment of frequently ill children: analysis of preferences of primary care pediatricians in choosing therapy
Objective: A survey of 464 primary care pediatricians was conducted to determine the choice of therapy for a group of frequently ill children depending on their length of service: from 3 to 10 years or more.Results: Recurrent acute respiratory infections are a complex problem for treating physicians. There is no consensus on the tactics of managing a group of frequently ill children among practicing pediatricians with different lengths of service. Preventive strategies come to the forefront to minimize the frequency of acute respiratory infections.
- 14 June 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (3)
TREATMENT OPTIONS FOR COUGH IN PEDIATRIC PRACTITIONER’S ROUTINE
Acute respiratory infections (ARI) are the main reason for morbidity in childhood. In ca. 90% of cases, they are accompanied by cough. The purpose of this research was to study the effectiveness and safety of the STODAL® drug in the treatment of cough in children. Materials and methods used: a multicenter prospective observational non-randomized clinical study was conducted involving 1000 outpatients with ARI aged 2 to 7 y/o and whose cough duration did not exceed 3 days from the onset of the disease. All of them were prescribed and treated with the complex homeopathic anticough drug on the day of their visit to pediatric practitioner in the outpatient hospital facilities. The patients were divided into two age groups as follows: G1 (n=500) of children aged 2 to 4 y/o and G2 (n=500) of children aged 4 years and 1 day old to 7 y/o. Results: on the 7th day of the therapy, a statistically significant decrease in the severity of daytime cough was noted: in G1 the severity of cough decreased by 1.51 points (from 2.16 to 0.65 points, p<0.001) and by 1.56 points (from 2.24 to 0.68 points, p<0.001) in G2. There was no difference in the reduction in daytime cough severity between the groups (p=0.158). The severity of night cough in G1 decreased by 1.16 points (from 1.64 to 0.48 points, p<0.001) and by 1.25 points (from 1.71 to 0.46 points, p<0.001) in G2. There were no differences in the dynamics of the severity of night cough between the groups as well (p=0.135). The proportion of patients whose cough resolved completely or became clinically insignificant on the 7th day of treatment was 98%, these patients were therefore considered recovered. Cough treatment was rated positively by 95.1% of parents/caretakers. Adverse events (AEs) were reported in 5 patients (0.5% of all cases) and there were no serious AEs among them. Conclusion: the effectiveness and safety of the STODAL® drug in the treatment of cough in ARI in children aged 2 to 7 y/o allows recommending a homeopathic drug with complex anti-inflammatory, antitussive and antimicrobial action for its inclusion in the treatment regimens starting from the first days of the disease.
- 14 June 2024
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 103 (3)
TREATMENT OPTIONS FOR COUGH IN PEDIATRIC PRACTITIONER’S ROUTINE
Acute respiratory infections (ARI) are the main reason for morbidity in childhood. In ca. 90% of cases, they are accompanied by cough. The purpose of this research was to study the effectiveness and safety of the STODAL® drug in the treatment of cough in children. Materials and methods used: a multicenter prospective observational non-randomized clinical study was conducted involving 1000 outpatients with ARI aged 2 to 7 y/o and whose cough duration did not exceed 3 days from the onset of the disease. All of them were prescribed and treated with the complex homeopathic anticough drug on the day of their visit to pediatric practitioner in the outpatient hospital facilities. The patients were divided into two age groups as follows: G1 (n=500) of children aged 2 to 4 y/o and G2 (n=500) of children aged 4 years and 1 day old to 7 y/o. Results: on the 7th day of the therapy, a statistically significant decrease in the severity of daytime cough was noted: in G1 the severity of cough decreased by 1.51 points (from 2.16 to 0.65 points, p<0.001) and by 1.56 points (from 2.24 to 0.68 points, p<0.001) in G2. There was no difference in the reduction in daytime cough severity between the groups (p=0.158). The severity of night cough in G1 decreased by 1.16 points (from 1.64 to 0.48 points, p<0.001) and by 1.25 points (from 1.71 to 0.46 points, p<0.001) in G2. There were no differences in the dynamics of the severity of night cough between the groups as well (p=0.135). The proportion of patients whose cough resolved completely or became clinically insignificant on the 7th day of treatment was 98%, these patients were therefore considered recovered. Cough treatment was rated positively by 95.1% of parents/caretakers. Adverse events (AEs) were reported in 5 patients (0.5% of all cases) and there were no serious AEs among them. Conclusion: the effectiveness and safety of the STODAL® drug in the treatment of cough in ARI in children aged 2 to 7 y/o allows recommending a homeopathic drug with complex anti-inflammatory, antitussive and antimicrobial action for its inclusion in the treatment regimens starting from the first days of the disease.
- 17 August 2020
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 99 (4)
TREATMENT OPTIONS FOR COUGH IN CHILDREN WITH ACUTE RESPIRATORY INFECTION
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.
- 17 August 2020
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 99 (4)
TREATMENT OPTIONS FOR COUGH IN CHILDREN WITH ACUTE RESPIRATORY INFECTION
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.
- 10 December 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (6)
ROLE OF SLEEP DISORDERS IN THE DEVELOPMENT OF OBESITY AND GASTROENTEROLOGICAL PATHOLOGY IN CHILDREN
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.
- 10 December 2019
- Published by Pediatria, Ltd. in Pediatria. Journal named after G.N. Speransky
- Vol. 98 (6)
ROLE OF SLEEP DISORDERS IN THE DEVELOPMENT OF OBESITY AND GASTROENTEROLOGICAL PATHOLOGY IN CHILDREN
Облако Mail.ru - это ваше персональное надежное хранилище в интернете.